{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:12:36Z","timestamp":1790993556093,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,18]]},"DOI":"10.7759\/cureus.29307","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T06:39:27Z","timestamp":1663569567000},"source":"Crossref","is-referenced-by-count":26,"title":["Vitiligo: A Narrative Review Article"],"prefix":"10.7759","author":[{"given":"Rutuja R","family":"Joge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush U","family":"Kathane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv H","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0749.2003.00070.x","article-title":"A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?","volume":"16","author":"Gauthier Y","year":"2003","unstructured":"Gauthier Y, Cario Andre M, Ta\u00efeb A. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?. Pigment Cell Res. 2003, 16:322-32. 10.1034\/j.1600-0749.2003.00070.x","journal-title":"Pigment Cell Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A review of the worldwide prevalence of vitiligo in children\/adolescents and adults","volume":"51","author":"Kr\u00fcger C","year":"2012","unstructured":"Kr\u00fcger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children\/adolescents and adults. Int J Dermatol. 2012, 51:1206-12. 10.1111\/j.1365-4632.2011.05377.x","journal-title":"Int J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn JG","year":"2009","unstructured":"van den Boorn JG, Konijnenberg D, Dellemijn TA, et al.. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol. 2009, 129:2220-32. 10.1038\/jid.2009.32","journal-title":"J Invest Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.11.010","article-title":"Current and emerging treatments for vitiligo","volume":"77","author":"Rodrigues M","year":"2017","unstructured":"Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. Current and emerging treatments for vitiligo. J Am Acad Dermatol. 2017, 77:17-29. 10.1016\/j.jaad.2016.11.010","journal-title":"J Am Acad Dermatol"},{"key":"ref5","article-title":"Disorders of hypopigmentation","volume":"18","author":"Dina Y","year":"2019","unstructured":"Dina Y, McKesey J, Pandya AG. Disorders of hypopigmentation. J Drugs Dermatol. 2019, 18:s115-6.","journal-title":"J Drugs Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2016.09.024","article-title":"Endogenously produced nonclassical vitamin D hydroxy-metabolites act as \"biased\" agonists on VDR and inverse agonists on ROR\u03b1 and ROR\u03b3","volume":"173","author":"Slominski AT","year":"2017","unstructured":"Slominski AT, Kim TK, Hobrath JV, et al.. Endogenously produced nonclassical vitamin D hydroxy-metabolites act as \"biased\" agonists on VDR and inverse agonists on ROR\u03b1 and ROR\u03b3. J Steroid Biochem Mol Biol. 2017, 173:42-56. 10.1016\/j.jsbmb.2016.09.024","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.08.017","article-title":"High-potency steroid use in children with vitiligo: a retrospective study","volume":"56","author":"Kwinter J","year":"2007","unstructured":"Kwinter J, Pelletier J, Khambalia A, Pope E\r\n. High-potency steroid use in children with vitiligo: a retrospective study. J Am Acad Dermatol. 2007, 56:236-41. 10.1016\/j.jaad.2006.08.017","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-6649rev","article-title":"Human skin pigmentation: melanocytes modulate skin color in response to stress","volume":"21","author":"Costin GE","year":"2007","unstructured":"Costin GE, Hearing VJ. Human skin pigmentation: melanocytes modulate skin color in response to stress. FASEB J. 2007, 21:976-94. 10.1096\/fj.06-6649rev","journal-title":"FASEB J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtumed.2021.04.012","article-title":"Impact of narrow-band ultraviolet B radiation therapy on the quality of life of patients with vitiligo","volume":"16","author":"Khojah HM","year":"2021","unstructured":"Khojah HM, Alharbi AG, Alshaeri AA, Alahmadi YM, Elbadawy HM. Impact of narrow-band ultraviolet B radiation therapy on the quality of life of patients with vitiligo. J Taibah Univ Med Sci. 2021, 16:843-8. 10.1016\/j.jtumed.2021.04.012","journal-title":"J Taibah Univ Med Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.4.1385","article-title":"Innervation of melanocytes in human skin","volume":"184","author":"Hara M","year":"1996","unstructured":"Hara M, Toyoda M, Yaar M, Bhawan J, Avila EM, Penner IR, Gilchrest BA. Innervation of melanocytes in human skin. J Exp Med. 1996, 184:1385-95. 10.1084\/jem.184.4.1385","journal-title":"J Exp Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2011.00898.x","article-title":"L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions","volume":"25","author":"Slominski A","year":"2012","unstructured":"Slominski A, Zmijewski MA, Pawelek J. L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions. Pigment Cell Melanoma Res. 2012, 25:14-27. 10.1111\/j.1755-148X.2011.00898.x","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780138","article-title":"Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site","volume":"80","author":"van den Wijngaard R","year":"2000","unstructured":"van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, Tigges B, Westerhof W, Das P. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest. 2000, 80:1299-309. 10.1038\/labinvest.3780138","journal-title":"Lab Invest"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1590\/s0365-05962013000100009","article-title":"Mechanisms regulating melanogenesis","volume":"88","author":"Videira IF","year":"2013","unstructured":"Videira IF, Moura DF, Magina S. Mechanisms regulating melanogenesis. An Bras Dermatol. 2013, 88:76-83. 10.1590\/s0365-05962013000100009","journal-title":"An Bras Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00044.2003","article-title":"Melanin pigmentation in mammalian skin and its hormonal regulation","volume":"84","author":"Slominski A","year":"2004","unstructured":"Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 2004, 84:1155-228. 10.1152\/physrev.00044.2003","journal-title":"Physiol Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.02101.x","article-title":"Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients","volume":"21","author":"Fai D","year":"2007","unstructured":"Fai D, Cassano N, Vena GA. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients. J Eur Acad Dermatol Venereol. 2007, 21:916-20. 10.1111\/j.1468-3083.2006.02101.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New discoveries in the pathogenesis and classification of vitiligo","volume":"77","author":"Rodrigues M","year":"2017","unstructured":"Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017, 77:1-13. 10.1016\/j.jaad.2016.10.048","journal-title":"J Am Acad Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.24625.1","article-title":"Recent advances in understanding the molecular basis of melanogenesis in melanocytes","volume":"9","author":"Ohbayashi N","year":"2020","unstructured":"Ohbayashi N, Fukuda M. Recent advances in understanding the molecular basis of melanogenesis in melanocytes. F1000Res. 2020, 9:10.12688\/f1000research.24625.1","journal-title":"F1000Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1729737","article-title":"Safety of the current drug treatments for vitiligo","volume":"19","author":"Lotti T","year":"2020","unstructured":"Lotti T, Agarwal K, Podder I, et al.. Safety of the current drug treatments for vitiligo. Expert Opin Drug Saf. 2020, 19:499-511. 10.1080\/14740338.2020.1729737","journal-title":"Expert Opin Drug Saf"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17071144","article-title":"Signaling pathways in melanogenesis","volume":"17","author":"D'Mello SA","year":"2016","unstructured":"D'Mello SA, Finlay GJ, Baguley BC, Askarian-Amiri ME. Signaling pathways in melanogenesis. Int J Mol Sci. 2016, 17:1144. 10.3390\/ijms17071144","journal-title":"Int J Mol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2003.00815.x","article-title":"Squamous cell carcinoma in vitiligo lesion after long-term PUVA therapy","volume":"17","author":"Park HS","year":"2003","unstructured":"Park HS, Lee YS, Chun DK. Squamous cell carcinoma in vitiligo lesion after long-term PUVA therapy. J Eur Acad Dermatol Venereol. 2003, 17:578-80. 10.1046\/j.1468-3083.2003.00815.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13680","article-title":"Therapeutic management of vitiligo","volume":"16","author":"Bleuel R","year":"2018","unstructured":"Bleuel R, Eberlein B. Therapeutic management of vitiligo. J Dtsch Dermatol Ges. 2018, 16:1309-13. 10.1111\/ddg.13680","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine K","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet Lond Engl. 2015, 386:74-84. 10.1016\/S0140-6736(14)60763-7","journal-title":"Lancet Lond Engl"},{"key":"ref23","article-title":"Vitiligo management update","volume":"5","author":"Westerhof W","year":"2000","unstructured":"Westerhof W. Vitiligo management update. Skin Ther Lett. 2000, 5:1-2,5.","journal-title":"Skin Ther Lett"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12143","article-title":"Vitiligo nonsurgical treatment: a review of latest treatment researches","volume":"27","author":"Zhang Y","year":"2014","unstructured":"Zhang Y, Mooneyan-Ramchurn JS, Zuo N, Feng Y, Xiao S. Vitiligo nonsurgical treatment: a review of latest treatment researches. Dermatol Ther. 2014, 27:298-303. 10.1111\/dth.12143","journal-title":"Dermatol Ther"},{"key":"ref25","article-title":"[Vitiligo--loss of cutaneous pigmentation]","volume":"126","author":"Sitek JC","year":"2006","unstructured":"Sitek JC. [Vitiligo--loss of cutaneous pigmentation]. Tidsskr Nor Laegeforen. 2006, 126:2370-2.","journal-title":"Tidsskr Nor Laegeforen"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20142717","article-title":"Vitiligo--part 2--classification, histopathology and treatment","volume":"89","author":"Faria AR","year":"2014","unstructured":"Faria AR, Tarl\u00e9 RG, Dellatorre G, Mira MT, Castro CC. Vitiligo--part 2--classification, histopathology and treatment. An Bras Dermatol. 2014, 89:784-90. 10.1590\/abd1806-4841.20142717","journal-title":"An Bras Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo: a comprehensive overview part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up","volume":"65","author":"Alikhan A","year":"2011","unstructured":"Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011, 65:473-91. 10.1016\/j.jaad.2010.11.061","journal-title":"J Am Acad Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15743","article-title":"Vitiligo: a focus on pathogenesis and its therapeutic implications","volume":"48","author":"Bergqvist C","year":"2021","unstructured":"Bergqvist C, Ezzedine K. Vitiligo: a focus on pathogenesis and its therapeutic implications. J Dermatol. 2021, 48:252-70. 10.1111\/1346-8138.15743","journal-title":"J Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1159\/000506103","article-title":"Vitiligo: a review","volume":"236","author":"Bergqvist C","year":"2020","unstructured":"Bergqvist C, Ezzedine K. Vitiligo: a review. Dermatology. 2020, 236:571-92. 10.1159\/000506103","journal-title":"Dermatology"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8622-7","article-title":"Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy","volume":"54","author":"Boniface K","year":"2018","unstructured":"Boniface K, Seneschal J, Picardo M, Ta\u00efeb A. Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy. Clin Rev Allergy Immunol. 2018, 54:52-67. 10.1007\/s12016-017-8622-7","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/110120-vitiligo-a-narrative-review-article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:16Z","timestamp":1707507556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/110120-vitiligo-a-narrative-review-article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,18]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.29307","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,18]]}}}